Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Obese, Vitamin D Deficiency, Low HDL
Interventions: Vitamin D; Dietary Supplement
Lead sponsor: Xiang-An Li; Other
Eligibility: 5 Years to 18 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Overweight, Obesity
Interventions: Toolkit Intervention; Behavioral
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 14 Years to 20 Years
Enrollment: 14,520 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Childhood Overweight, Childhood Obesity
Interventions: SFM+ Low Dose, Weight Maintenance Education, SFM+ High Dose; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 7 Years to 11 Years
Enrollment: 482 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: St Louis, Missouri • Seattle, Washington

Conditions: Obesity or Overweight, Diabetes Mellitus, Type 2
Interventions: Lenbelintide, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 56
States / cities: Fairhope, Alabama • Huntsville, Alabama • Mobile, Alabama + 49 more

Conditions: Obesity
Interventions: oleoyl-estrone (MP 101); Drug
Lead sponsor: Manhattan Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 2
States / cities: Baton Rouge, Louisiana • Salt Lake City, Utah

Conditions: Spinal Cord Injuries, Obesity, Cardiometabolic Syndrome
Interventions: Telenutrition; Behavioral
Lead sponsor: Santa Clara Valley Health & Hospital System; Other
Eligibility: 20 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: San Jose, California

Conditions: Obesity
Interventions: Behavioral weight loss; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Neural Response in Caudate, Weight Loss Trial, Impulsivity
Interventions: PhosphoLean, Placebo; Dietary Supplement
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pediatric Obesity, Pediatric Overweight
Interventions: Multifamily weight management intervention; Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 8 Years to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Child Obesity
Interventions: Parenting Mindfully for Health Nutrition (PMH), Contact Control Nutrition (C+N), Non-randomized historical control (WLC) assessment only; Behavioral · Other
Lead sponsor: Yale University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 246 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Impaired Glucose Tolerance, Prediabetes
Interventions: CGM; Device
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 10 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Obesity, Overweight
Interventions: Brenipatide, Placebo; Drug · Other
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Daytona Beach, Florida • Dallas, Texas • Madison, Wisconsin

Conditions: Insulin Sensitivity
Interventions: Blueberry Powder, Placebo; Dietary Supplement
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 20 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Obesity, Overweight
Interventions: Eloralintide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 43
States / cities: Chandler, Arizona • Scottsdale, Arizona • Tucson, Arizona + 37 more

Conditions: Childhood Obesity, Obesity
Interventions: Mother with obesity, daughter with obesity, Mother with obesity, daughter without obesity, Mother without obesity, daughter with obesity, Mother without obesity, daughter without obesity, Mother with obesity, son with obesity, Mother with obesity, son without obesity, Mother without obesity, son with obesity, Mother without obesity, son without obesity, Father with obesity, daughter with obesity, Father with obesity, daughter without obesity, Father without obesity, daughter with obesity, Father without obesity, daughter without obesity, Father with obesity, son with obesity, Father with obesity, son without obesity, Father without obesity, son with obesity, Father without obesity, son without obesity; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 1,973 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pediatric Obesity, Pediatric Asthma
Interventions: Pro2 - 60% of participant's MIP, Pro2 - 15% of participant's MIP; Device
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Asthma
Interventions: Seeking Health Probiota Bifido; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 99 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2), Screening Colonoscopy
Interventions: Colonoscopy; Device
Lead sponsor: Cleveland Clinic Florida; Other
Eligibility: Not listed
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Obesity, Overweight, Prediabetes, Weight Loss, Lifestyle
Interventions: Wearable technology, smartscale, Smartphone applications, Standard Weight Management Visits; Device · Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Childhood, Diet, Healthy, Body Weight Changes
Interventions: Whole Foods MyPlate Group; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 10 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity
Interventions: Behavioral weight loss intervention (Online; Rx Weight Loss), Minority stress intervention, Social support intervention, Negative body image intervention; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Body Fat Disorder
Interventions: The Zeltiq CoolSculpting System; Device
Lead sponsor: Zeltiq Aesthetics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 2
States / cities: Sacramento, California • Dallas, Texas

Conditions: OBESITY, HYPERTENSION, PURE AUTONOMIC FAILURE, SHY-DRAGER SYNDROME
Interventions: Trimethaphan, Pseudoephedrine; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Visceral Obesity, Insulin Resistance
Interventions: Water-only fasting; Other
Lead sponsor: TrueNorth Health Foundation; Other
Eligibility: 40 Years to 70 Years
Enrollment: 48 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Santa Rosa, California

Search by objective public record fields.

Roles of Vitamin D and HDL in Obese Children

Wellness Program Implementation: School & Student Toolkits

Childhood Obesity Treatment: A Maintenance Approach

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Telenutrition for Individuals With SCI

The Use of the Internet to Facilitate Weight Loss and Maintenance.

The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity

Reducing Barriers to Behavior Change Among Youth With Pediatric Overweight and Obesity

Preventing Childhood Obesity Through a Mindfulness-Based Parent Stress Intervention

CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance

A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

The Effect of Blueberries on Enhancing Insulin Sensitivity in Humans: A Pilot Study

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

Weight Stigma by Association in Parent-Child Dyads

Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma

Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects

Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.

Smart Technology for Weight Loss and Metabolic Health

Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity

Optimizing an Online Behavioral Weight Loss Intervention and Novel Culturally Tailored Components for Sexual Minority Women

CoolSculpting of the Flank With Alternate Treatment Parameters

The Autonomic Nervous System and Obesity

The Effects of Water-only Fasting and Refeeding on Body Composition